| The role of the Hedgehog signaling pathway in cancer: A comprehensive review AM Skoda, D Simovic, V Karin, V Kardum, S Vranic, L Serman Bosnian journal of basic medical sciences, 2018 | 756 | 2018 |
| The 2019 WHO classification of tumours of the breast PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ... Histopathology 77 (2), 2020 | 722 | 2020 |
| Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type Z Gatalica, C Snyder, T Maney, A Ghazalpour, DA Holterman, N Xiao, ... Cancer epidemiology, biomarkers & prevention 23 (12), 2965-2970, 2014 | 576 | 2014 |
| Molecular characterization of cancers with NTRK gene fusions Z Gatalica, J Xiu, J Swensen, S Vranic Modern Pathology 32 (1), 147-153, 2019 | 496 | 2019 |
| Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements A Malki, RA ElRuz, I Gupta, A Allouch, S Vranic, AE Al Moustafa International journal of molecular sciences 22 (1), 130, 2020 | 364 | 2020 |
| WHO classification of tumours WHO Classification of Tumours Editorial Board Digestive system tumours, 2019 | 195 | 2019 |
| High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine Z Gatalica, S Vranic, J Xiu, J Swensen, S Reddy Familial cancer 15 (3), 405-412, 2016 | 193 | 2016 |
| A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells XT Zhang, LG Kang, L Ding, S Vranic, Z Gatalica, ZY Wang Oncogene 30 (7), 770-780, 2011 | 191 | 2011 |
| PD-L1 status in breast cancer: Current view and perspectives S Vranic, FS Cyprian, Z Gatalica, J Palazzo Seminars in cancer biology 72, 146-154, 2021 | 139 | 2021 |
| EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast S Vranic, O Tawfik, J Palazzo, N Bilalovic, E Eyzaguirre, LMJ Lee, ... Modern pathology 23 (5), 644-653, 2010 | 127 | 2010 |
| Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1 U Joneja, S Vranic, J Swensen, R Feldman, W Chen, J Kimbrough, ... Journal of clinical pathology, jclinpath-2016-203874, 2017 | 125 | 2017 |
| Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: a new clinical paradigm in the treatment of triple-negative breast cancer FS Cyprian, S Akhtar, Z Gatalica, S Vranic Bosnian Journal of Basic Medical Sciences 19 (3), 227, 2019 | 123 | 2019 |
| Predictive biomarker profiling of> 6000 breast cancer patients shows heterogeneity in TNBC, with treatment implications SZ Millis, Z Gatalica, J Winkler, S Vranic, J Kimbrough, S Reddy, ... Clinical breast cancer 15 (6), 473-481. e3, 2015 | 119 | 2015 |
| Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy Z Gatalica, J Xiu, J Swensen, S Vranic European journal of cancer 94, 179-186, 2018 | 104 | 2018 |
| Apocrine carcinoma of the breast: a comprehensive review S Vranic, F Schmitt, A Sapino, JL Costa, S Reddy, M Castro, Z Gatalica F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de …, 2013 | 101 | 2013 |
| Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Z Gatalica, N Bilalovic, JP Palazzo, RP Bender, J Swensen, SZ Millis, ... Oncotarget 6 (23), 19819, 2015 | 96 | 2015 |
| Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin SZ Millis, D Bryant, G Basu, R Bender, S Vranic, Z Gatalica, NJ Vogelzang Clinical genitourinary cancer 13 (1), e37-e49, 2015 | 90 | 2015 |
| Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17 S Vranic, B Teruya, S Repertinger, P Ulmer, J Hagenkord, Z Gatalica Cancer 117 (1), 48-53, 2011 | 90 | 2011 |
| Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases Z Gatalica, SZ Millis, S Vranic, R Bender, GD Basu, A Voss, DD Von Hoff Oncotarget 5 (23), 12440, 2014 | 89 | 2014 |
| ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast S Vranic, Z Gatalica, H Deng, S Frkovic-Grazio, LMJ Lee, O Gurjeva, ... Journal of clinical pathology, jcp. 2010.082776, 2011 | 85 | 2011 |
Ala-Eddin Al Moustafa, PhDProf., College of Medicine, Qatar University & Adjunct Prof., Oncology Dept., McGill UniversityAdresse e-mail validée de qu.edu.qa
